Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection

ClinicalTrials.gov ID: NCT00023452

Public ClinicalTrials.gov record NCT00023452. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

TBTC Study 26: Effectiveness and Tolerability of Weekly Rifapentine/Isoniazid for 3 Months Versus Daily Isoniazid for 9 Months for the Treatment of Latent Tuberculosis Infection

Study identification

NCT ID
NCT00023452
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Centers for Disease Control and Prevention
Federal
Enrollment
8,053 participants

Conditions and interventions

Conditions

Interventions

  • RPT + INH once weekly for 3 months given by DOT Drug
  • Isoniazid (INH) daily for 9 months Drug

Drug

Eligibility (public fields only)

Age range
2 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2001
Primary completion
Sep 30, 2010
Completion
Aug 31, 2013
Last update posted
Aug 26, 2024

2001 – 2013

United States locations

U.S. sites
21
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
Central Arkansas Veterans Health System Little Rock Arkansas 72205
LA County/USC Medical Center Los Angeles California 90033
UCSD Medical Center San Diego California 92103
University of California, San Francisco San Francisco California 94110
Denver Department of Public Health and Hospitals Denver Colorado 80204
Washington, D.C. VAMC Washington D.C. District of Columbia 20422
Emory University, Department of Medicine Atlanta Georgia 30303
Chicago VA Medical Center (Lakeside) Chicago Illinois 60611
Hines VA Medical Center Hines Illinois 60141
Johns Hopkins University School of Medicine Baltimore Maryland 21287-0003
Boston Medical Center Boston Massachusetts 02118
New Jersey Medical School Newark New Jersey 07107-3001
Columbia University/Presbyterian Medical Center New York New York 10032
Harlem Hospital Center New York New York 10037
Carolinas Medical Center Charlotte North Carolina 28203
Duke University Medical Center Durham North Carolina 34222
Vanderbilt University Medical Center Nashville Tennessee 37232
University of North Texas Health Science Center Fort Worth Texas 76107-2699
Michael Debakey Veterans Affairs Medical Center Houston Texas 77009
Audi L. Murphy VA Hospital San Antonio Texas 78284
Seattle King County Health Department Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00023452, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 26, 2024 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00023452 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →